Purpose The purpose of the study is to estimate the EQ-5D-derived health utilities
associated with selected chronic conditions (hypertension, heart disease, arthritis, asthma or …

Objective This study assessed patient-reported health-related quality of life (HRQoL) using
two generic preference-based measures in Chinese patients with spinal and bulbar …

Several cost-effectiveness models of disease-modifying treatments (DMTs) for multiple
sclerosis (MS) have been developed for different populations and different countries. Vast …

OBJECTIVE: To derive robust estimates for the cost of multiple sclerosis (MS) based on a
variety of cost factors across a number of different cost perspectives. This is essential to …

Purpose Summarizing patient-reported outcomes (PROs) on a quality-adjusted life year
(QALY) scale is an essential component to any economic evaluation comparing alternative …

We performed a cross-sectional, bottom-up observational study of resource consumption
and quality of life of patients with multiple sclerosis (MS) in the United Kingdom. Three …

This study systematically compares HTA recommendations on a number of disease–
modifying therapies for patients with Relapsing-Remitting Multiple Sclerosis. We analysed …

Abstract Background Economic costs of Multiple Sclerosis (MS) in Australia were last
estimated in 2010 and are likely to have changed over time, especially given this new era of …

Importance: Many cost-utility analyses rely on generic utility measures for estimates of
disease impact. Commonly used generic preference-based indexes may generate different …

Objective. To compare measurement properties of the EQ-5D and SF-6D utility measures, to
assess the association and agreement between these measures and to estimate minimal …